Examples of using Use in patients with severe in English and their translations into Swedish
{-}
-
Medicine
-
Colloquial
-
Official
-
Ecclesiastic
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
-
Political
Use in patients with severe renal impairment has not been studied.
Asthma Aerivio Spiromax is for use in patients with severe asthma only.
Use in patients with severe renal impairment creatinine clearance.
Pixuvri is not recommended for use in patients with severe excretory hepatic impairment, see section 4.3.
Use in patients with severe hepatic impairment is not recommended.
Patients with hepatic impairment: Rasagiline use in patients with severe hepatic impairment is contraindicated see section 4.3.
Use in patients with severe hepatic impairment is not recommended.
to any of the excipients listed in section 6.1. Use in patients with severe renal insufficiency or severe hepatic impairment.
Use in patients with severe hepatic impairment see section 4.2.
is not recommended for use in patients with severe hepatic impairment see section 4.2.
Therefore use in patients with severe hepatic impairment is not recommended.
hepatic impairment and therefore its use in patients with severe hepatic impairment cannot be recommended see section 5.2.
Use in patients with severe renal insufficiency or severe hepatic impairment.
As no data are available, the use in patients with severe hepatic impairment is not recommended see sections 4.4 and 5.2.
The use in patients with severe renal impairment(CLCR<
Sugammadex is not recommended for use in patients with severe renal impairment,
Use in patients with severe renal impairment(creatinine clearance<
Rasagiline use in patients with severe hepatic impairment is contraindicated see section 4.3.
Use in patients with severe renal insufficiency Caution should be exercised when using ivabradine in patients with severe renal insufficiency(creatinine clearance< 15 ml/ min) see section 4.2.
Airsonett Air4 is for use in patients with severe allergic asthma who, in spite of taking asthma medication, still have poorly controlled asthma.
As use in patients with severe hepatic impairment may be associated with increased exposure of netupitant, Akynzeo should be used with caution in these patients see sections 4.4 and 5.2.
The safety and efficacy of Resolor for use in patients with severe and clinically unstable concomitant disease(e.g. cardiovascular
OSSEOR is only indicated for use in patients with severe osteoporosis at high risk of fracture, for whom treatment with other medicinal products approved for the treatment of osteoporosis is not possible due to, for example, contraindications or intolerance.
Tolucombi should not be used in patients with severe renal impairment creatinine clearance.
Tandemact should not be used in patients with severe renal function disorders creatinine clearance.
FORSTEO should not be used in patients with severe renal impairment see 4.3.
Docetaxel must not be used in patients with severe liver impairment since there is no data available see sections 4.2 and 4.4.
Tandemact should not be used in patients with severe renal function disorders creatinine clearance<
Losartan/ HCTZ tablets must not be used in patients with severe renal impairment(i. e. creatinine clearance< 30 ml/ min) see section 4.3.
The combination should be used in patients with severe hepatic impairment only if the anticipated benefit exceeds the risk.